50 results
8-K
EX-99.1
OCUP
Ocuphire Pharma Inc
13 Nov 23
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
8:12am
Congress in October 2023.
An oral presentation delivered by Anat Lowenstein, M.D., at the 56th Annual Retina Society Scientific Meeting in October
8-K
EX-99.1
OCUP
Ocuphire Pharma Inc
11 Aug 23
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
9:27am
and Ophthalmology (ARVO) Annual Meeting in April 2023, and at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in May 2023
8-K
EX-99.1
wdgx0x0t
15 May 23
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
8:07am
8-K
EX-99.1
wnvib9f7i xx435
14 Oct 22
Regulation FD Disclosure
11:32am
8-K
EX-99.1
nsg za934jdduk
12 Aug 22
Ocuphire Pharma Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update
7:51am
8-K
EX-99.1
hzz e4ybz0bpsbym
24 Mar 22
Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended 2021 and Provides Corporate Update
8:17am
8-K
EX-99.1
ejjtxd1
15 Nov 21
Ocuphire Announces Financial Results for the Third Quarter 2021 and Provides Corporate Update
12:00am
8-K
EX-99.1
84camf5bl9
12 Aug 21
Ocuphire Announces Financial Results for the Second Quarter 2021 and Provides Corporate Update
7:31am
8-K
EX-99.2
vo82bkunzej
30 Jun 21
Regulation FD Disclosure
9:17am
8-K
EX-99.1
fwsxym45c4m6ybfdna
7 May 21
Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update
4:01pm